SPRINT: Lower Blood Pressure Target May Reduce Mortality, Cardiovascular Events
Results from the SPRINT trial suggest that a systolic blood pressure target of 120 mm Hg instead of 140 mm Hg may prevent CV events.
Results from the SPRINT trial suggest that a systolic blood pressure target of 120 mm Hg instead of 140 mm Hg may prevent CV events.
Disclosing genetic risk information resulted in lower LDL cholesterol levels in patients at risk for coronary heart disease.
A decrease was noted in the number of people who score highly on 7 metrics of cardiovascular health defined by the AHA.
Physicians may need to ask young adults about energy drink intake in emergency settings.
Only one-third to one-half of eligible Hispanic patients studied are taking statins or other lipid-lowering therapies.
Mortality rate is higher among women with heart disease after discharge from the hospital.
Obese children as young as age 8 years have signs of heart disease and heart muscle abnormalities.
Results from the Fifty-Fifty trial demonstrated the success of peer support in reducing cardiovascular risk factors.
Many women in the United States do not feel personally connected to the risk of heart disease.
Personalized medications based on a patient’s medical and biological profiles may be possible with 3D printing.